4//SEC Filing
Zeng Ling 4
Accession 0001399529-21-000012
CIK 0001399529other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 9:37 PM ET
Size
8.0 KB
Accession
0001399529-21-000012
Insider Transaction Report
Form 4
Zeng Ling
Chief Legal Officer & Sec'y
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-01-12+46,120→ 46,120 totalExercise: $24.05Exp: 2031-01-11→ Common Stock (46,120 underlying) - Award
Restricted Stock Units
2021-01-12+10,250→ 10,250 total→ Common Stock (10,250 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of December 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.
- [F3]The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2021, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued employment or service with the Issuer through each applicable vesting date.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeother
Related Parties
1- filerCIK 0001824252
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 9:37 PM ET
- Size
- 8.0 KB